Objective
Not all cancer cells are born equal. It could be demonstrated that tumors are formed by different cell types, mostly exhibiting a limited potential of proliferation. Further, it was shown that malignant tumor behaviour is fuelled by a minority of key-players harbouring the ability to form new tumors after transplantation. Such tumor founding cells share multiple characteristics with stem cells, and thus, are often called “cancer stem cells (CSC)”. With this regards, most anticancer treatments fail to be curative because they focus on the large cell population, but not on CSC. This illustrates the need to develop more efficient therapies. However, such developments should be preceded by (1) better understanding of the mechanisms controlling normal stem cell fate decisions, (2) identification of the mechanisms that differ between CSC and their normal counterparts.
In the present project, we plan to characterise mechanisms implicated in self-renewal and differentiation of neural stem cells (NSC) and to compare these data with brain tumor stem cells (BTSC). For this, we aim to establish microarray based transcriptomic and miRNA signatures of NSC, and of cells for which neuronal and astrocytic differentiation has been induced. To these signatures, we want to compare the transcriptomic profiles of BTSC, and thus, to isolate common and differentiating molecular events. The transcriptomic profiling will be completed by studying the impact of specific chemical compounds on stem cell behaviour. In fact, identifying drugs that artificially induce stem cell differentiation might be useful to induce differentiation and exhaustion of the CSC population. Finally, we aim to establish in vitro and in vivo models to verify the functional aspects of the obtained data. Together, our data would have an extensive impact on understanding the mechanisms implicated in NSC fate decisions and in BTSC development, a first step towards the development of efficient therapies.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences medical biotechnology cells technologies stem cells
- medical and health sciences clinical medicine oncology
- medical and health sciences clinical medicine transplantation
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2009-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
Berlin
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.